arrow_back Trending Legislation
Share share

Abortion Drug Restrictions: New Rules and Requirements for Doctors

This bill introduces strict new rules for abortion drugs. Citizens should be aware that new abortion drugs will not be approved, and existing ones will face significant restrictions on access and use. Requirements for doctors prescribing these drugs and adverse event reporting will also change.
Key points
Prohibition on approving new abortion drugs and related research.
Previously approved abortion drugs can only be used up to 70 days gestation and must be administered in-person by a prescribing healthcare practitioner in a medical setting.
Healthcare practitioners prescribing abortion drugs will need special certification and skills, including the ability to diagnose ectopic pregnancies and provide surgical intervention.
All serious adverse events, including fatalities and hospitalizations, related to abortion drug use, must be reported to relevant authorities.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
SAVE Moms and Babies Act of 2023
Print number: HR 427
Sponsor: Rep. Latta, Robert E. [R-OH-5]
Process start date: 2023-01-20
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Abortion Drug Restrictions: New Rules and Requirements for Doctors

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 427.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-01-20.

What are the main provisions?

Key points include:

  • Prohibition on approving new abortion drugs and related research.
  • Previously approved abortion drugs can only be used up to 70 days gestation and must be administered in-person by a prescribing healthcare practitioner in a medical setting.
  • Healthcare practitioners prescribing abortion drugs will need special certification and skills, including the ability to diagnose ectopic pregnancies and provide surgical intervention.
  • All serious adverse events, including fatalities and hospitalizations, related to abortion drug use, must be reported to relevant authorities.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Latta, Robert E. [R-OH-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 427

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health